ESPR
Esperion Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$2.44
-0.03 ▼ -1.21%
🌙 3월 13일 7:59 PM ET (한국 3/14 08:59)
$2.52
+0.08 ▲ +3.22%
| Index | RUT | P/E | - | EPS (ttm) | -0.21 | Insider Own | 4.03% | Shs Outstand | 0.26B | Perf Week | -10.29% |
| Market Cap | 0.63B | Forward P/E | 35.88 | EPS next Y | 3.48% | Insider Trans | -1.01% | Shs Float | 0.25B | Perf Month | -29.48% |
| Enterprise Value | 1.01B | PEG | - | EPS next Q | -0.02 | Inst Own | 64.01% | Short Float | 13.6% | Perf Quarter | -36.29% |
| Income | -0.02B | P/S | 1.55 | EPS this Y | 159.74% | Inst Trans | 21.14% | Short Ratio | 6.76 | Perf Half Y | -12.54% |
| Sales | 0.40B | P/B | - | EPS next 5Y | - | ROA | -3.69% | Short Interest | 33.53M | Perf YTD | -34.05% |
| Book/sh | -1.23 | P/C | 3.73 | EPS past 3/5Y | 68.58% 53.87% | ROE | - | 52W High | -41.56% ($4.18) | Perf Year | 62.67% |
| Cash/sh | 0.65 | P/FCF | - | Sales past 3/5Y | 74.8% 12.12% | ROIC | -14.51% | 52W Low | 252.35% ($0.69) | Perf 3Y | -42.72% |
| Dividend Est. | - | EV/EBITDA | 16.68 | EPS Y/Y TTM | 27.38% | Gross Margin | 67.95% | Volatility(W/M) | 12.19% 6.98% | Perf 5Y | -91.96% |
| Dividend TTM | - | EV/Sales | 2.5 | Sales Y/Y TTM | 21.31% | Oper. Margin | 14.95% | ATR (14) | 0.22 | Perf 10Y | -84.23% |
| Dividend Ex-Date | - | Quick Ratio | 1.19 | EPS Q/Q | 299.36% | Profit Margin | -5.63% | RSI (14) | 29.52 | Recom | 1.71 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.54 | Sales Q/Q | 143.73% | SMA20 | -21.35% ($3.1) | Beta | 1.19 | Target Price | $6.97 |
| Payout | - | Debt/Eq | - | Earnings | 3000000 | SMA50 | -25.97% ($3.3) | Rel Volume | 1.17 | Prev Close | $2.47 |
| Employees | 294 | LT Debt/Eq | - | EPS/Sales Surpr. | -9.58% 1.2% | SMA200 | -5.47% ($2.58) | Avg Volume(3M) | 4.96M | Price | $2.44 |
| IPO | 2013/6/26 | Option/Short | Yes/Yes | Trades | 11427 | Volume | 5,817,427 | Change | -1.21% |
뉴스 로딩 중...